Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
346.30
-1.79 (-0.51%)
Sep 10, 2026, 12:51 PM EDT - Market open
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $10.25 billion as of September 10, 2026. Its market cap has increased by 150.80% in one year.
Market Cap
10.25B
Enterprise Value
9.16B
1-Year Change
150.80%
Ranking
Category
Stock Price
$346.30
ChartMarket Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $10.25B, an increase of 10,993.16%. That is a compound annual growth rate of 68.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 10.25B | 43.38% |
| Dec 31, 2025 | 7.15B | 58.67% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
| Sep 20, 2017 | 92.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 12.20B |
| Corcept Therapeutics | 12.07B |
| Bio-Techne | 11.36B |
| Axsome Therapeutics | 10.83B |
| Cytokinetics | 10.11B |
| ABIVAX Société Anonyme | 9.89B |
| Praxis Precision Medicines | 9.82B |
| Kymera Therapeutics | 9.76B |